Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Ixekizumab Clinical Trials Continue; FDA Updates Warning Label for Varenicline

Michele B. Kaufman, PharmD, CGP, RPh  |  June 15, 2015

It seems to have begun in Norway, the international pressure to switch patients from well-known brand biologic agents, such as Remicade (infliximab), to biosimilar agents, due to a significant cost advantage.1 This biosimilar came with a 39% price markdown last year compared with the brand, and when Norway called for bids, the discount went to…

Filed under:Biologics/DMARDsConditionsDrug UpdatesPsoriatic Arthritis Tagged with:Biologics & BiosimilarsinfliximabixekizumabPsoriatic ArthritisRheumatoid Arthritis (RA)

Rheumatoid Arthritis, Periodontal Disease Link Suggests Benefits in Behavioral Change

Karen Appold  |  June 15, 2015

Although compelling data exist to support a link between periodontal disease (PD) and the development of rheumatoid arthritis (RA), cementing the association will require extensive investigative work.1 However, in reviewing the literature of the past 10 years, Elliot D. Rosenstein, MD, director, Institute for Rheumatic and Autoimmune Diseases at Overlook Medical Center, Summit, N.J., and…

Filed under:ConditionsRheumatoid Arthritis Tagged with:behavior changebone losspatient carePeriodontal diseaseRheumatoid arthritisrheumatologist

Tips for Treating Insomnia in Rheumatology Patients

Linda Childers  |  June 15, 2015

Chronic insomnia is a common complaint for patients with rheumatic diseases and conditions. In fact, sleep disturbances are among the most common symptoms of both fibromyalgia and rheumatoid arthritis (RA), with more than 50% of chronic pain patients reporting sleep disturbances. Pain combined with insomnia can lead to a vicious cycle, says Ruth Gentry, PhD,…

Filed under:Conditions Tagged with:insomniapatient carerheumatologyTreatment

COPA Genetic Mutation Identified in Lung Disease, Arthritis

Lara C. Pullen, PhD  |  June 15, 2015

Researchers from California and Texas have identified a new genetic syndrome that is characterized by systemic autoimmune disease of the lung and joints. The syndrome is driven by a genetic variant of a vesicular transport protein and is the first documented association between intracellular transport and autoimmunity. Levi B. Watkin, PhD, postdoctoral fellow at Baylor…

Filed under:ConditionsResearch Rheum Tagged with:Arthritisautoimmunity syndromeCOPAgenetic mutationjointlung diseaseResearch

Disease Management Programs Help Patients Cope with Chronic Diseases

Mary Beth Nierengarten  |  June 15, 2015

For patients living with a chronic disease, such as rheumatoid arthritis or osteoarthritis, learning to manage and cope with the myriad adverse symptoms that accompany these diseases is key to improving quality of life and helping reduce the cost burden of these illnesses on the healthcare system. One important way rheumatologists can help is by…

Filed under:ConditionsPain SyndromesPractice SupportQuality Assurance/Improvement Tagged with:Chronic paindisease managementpatient carerheumatologist

Why Rheumatologist–Pulmonologist Collaboration Is Essential

Vanessa Caceres  |  June 15, 2015

Although close collaboration with a variety of specialists outside of rheumatology is important, you could make the case for rheumatologists and pulmonologists having to work together even more closely. If lung symptoms are severe and not under control, the results could be fatal. However, the question sometimes is when to refer—even when there are not…

Filed under:Practice SupportQuality Assurance/Improvement Tagged with:collaborationlung diseasepatient carepulmonologistrheumatologist

Institute of Medicine Recommends Changes in Graduate Medical Education

Richard Quinn  |  June 15, 2015

Questions, concerns and spirited debate have surrounded the Graduate Medical Education (GME) system for decades. The program that trains nearly 120,000 physicians per year is under constant scrutiny.1 Changes to the political landscape, combined with ongoing efforts by health industry payers and regulators to squeeze inefficiency out of the system, have kept the GME in…

Filed under:Education & TrainingProfessional Topics Tagged with:graduate medical educationInstitute of MedicinerecommendationTraining

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Redefined

Karen Appold  |  June 15, 2015

A report from the Institute of Medicine that gives new diagnostic criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and recommends a new name for the disorder received mixed reviews from rheumatologists and other physicians.1 “Diagnosing ME/CFS often is a challenge … the new diagnostic criteria will make it easier for clinicians to recognize and accurately…

Filed under:ConditionsResearch Rheum Tagged with:chronic fatigue syndromeDiagnostic CriteriaInstitute of Medicinemyalgic encephalomyelitispatient carerecommendationResearch

Rheumatology Fellowship Programs Could Benefit from Leadership Training

Katarzyna Gilek-Seibert, MD  |  June 15, 2015

The beep of the cellphone text got me off the armchair. I had been feeling cozy and comfortable. Outside the window, it was a blissful winter wonderland—the one, I believe, Nat King Cole intended when recording “The Christmas Song.” But at the same time, I was anxious to hear whether my clinic would be canceled…

Filed under:Education & TrainingProfessional Topics Tagged with:EducationfellowshipLeadershiprheumatologyTraining

Ethics Forum: Plagiarism in EMRs Saves Time, But Can Raise Risk of Errors

Jane S. Kang, MD, & Robert H. Shmerling, MD  |  June 15, 2015

Case You’ve been asked to see an inpatient for a rheumatologic consultation. After seeing the patient, you enter an initial consult note in the electronic medical record (EMR). The next day, when you write a follow-up note for this patient, you copy part of your assessment and plan from your prior note. Soon after you…

Filed under:EthicsProfessional TopicsTechnology Tagged with:Electronic medical recordsmedical errorsplagiarismTechnology

  • « Previous Page
  • 1
  • …
  • 243
  • 244
  • 245
  • 246
  • 247
  • …
  • 326
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences